相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Comparison of 2 new real-time polymerase chain reaction-based urinary markers in the follow-up of patients with non-muscle-invasive bladder cancer
Emanuela Trenti et al.
CANCER CYTOPATHOLOGY (2020)
The evolving role of PD-L1 testing in patients with metastatic urothelial carcinoma
Thomas Powles et al.
CANCER TREATMENT REVIEWS (2020)
Diagnostic Accuracy of MCM5 for the Detection of Recurrence in Nonmuscle Invasive Bladder Cancer Followup: A Blinded, Prospective Cohort, Multicenter European Study
Morgan Roupret et al.
JOURNAL OF UROLOGY (2020)
Predictive value of MCM5 (ADXBLADDER) analysis in urine of men evaluated for the initial diagnosis of bladder cancer: A comparative prospective study
Emanuela Anastasi et al.
DIAGNOSTIC CYTOPATHOLOGY (2020)
A Novel, non-invasive Test Enabling Bladder Cancer Detection in Urine Sediment of Patients Presenting with Haematuria-A Prospective Multicentre Performance Evaluation of ADXBLADDER
Tim Dudderidge et al.
EUROPEAN UROLOGY ONCOLOGY (2020)
Keynote 057: Phase II trial of Pembrolizumab (pembro) for patients (pts) with high-risk (HR) nonmuscle invasive bladder cancer (NMIBC) unresponsive to bacillus calmette-guerin (BCG).
Arjun Vasant Balar et al.
JOURNAL OF CLINICAL ONCOLOGY (2019)
Diagnostic predictive value of the Bladder EpiCheck test in the follow-up of patients with non-muscle-invasive bladder cancer
Emanuela Trenti et al.
CANCER CYTOPATHOLOGY (2019)
Diagnostic accuracy, clinical utility and influence on decision-making of a methylation urine biomarker test in the surveillance of non-muscle-invasive bladder cancer
David D'Andrea et al.
BJU INTERNATIONAL (2019)
An up-to-date catalog of available urinary biomarkers for the surveillance of non-muscle invasive bladder cancer
Francesco Soria et al.
WORLD JOURNAL OF UROLOGY (2018)
Performance of the Bladder EpiCheck™ Methylation Test for Patients Under Surveillance for Non-muscle-invasive Bladder Cancer: Results of a Multicenter, Prospective, Blinded Clinical Trial
J. Alfred Witjes et al.
EUROPEAN UROLOGY ONCOLOGY (2018)
Bladder Cancer Incidence and Mortality: A Global Overview and Recent Trends
Sebastien Antoni et al.
EUROPEAN UROLOGY (2017)
EAU Guidelines on Non-Muscle-invasive Urothelial Carcinoma of the Bladder: Update 2016
Marko Babjuk et al.
EUROPEAN UROLOGY (2017)
Pembrolizumab as Second-Line Therapy for Advanced Urothelial Carcinoma
J. Bellmunt et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
The Burden of Cystoscopic Bladder Cancer Surveillance: Anxiety, Discomfort, and Patient Preferences for Decision Making
Kevin Koo et al.
UROLOGY (2017)
The 2016 WHO Classification of Tumours of the Urinary System and Male Genital Organs-Part B: Prostate and Bladder Tumours
Peter A. Humphrey et al.
EUROPEAN UROLOGY (2016)
MOLECULAR URINE CYTOLOGY - BLADDER EPICHECK IS A NOVEL MOLECULAR DIAGNOSTIC TOOL FOR MONITORING OF BLADDER CANCER PATIENTS
Adam Wasserstrom et al.
JOURNAL OF UROLOGY (2016)
Diagnosis and Treatment of Non-Muscle Invasive Bladder Cancer: AUA/SUO Guideline
Sam S. Chang et al.
JOURNAL OF UROLOGY (2016)
Current Status of Urinary Biomarkers for Detection and Surveillance of Bladder Cancer
Aurelie Mbeutcha et al.
UROLOGIC CLINICS OF NORTH AMERICA (2016)
Prognostic value of urinary cytology and other biomarkers for recurrence and progression in bladder cancer: a prospective study
Michael D. Bell et al.
WORLD JOURNAL OF UROLOGY (2016)
Immune checkpoint blockade in hematologic malignancies
Philippe Armand
BLOOD (2015)
Prospective analysis of sensitivity and specificity of urinary cytology and other urinary biomarkers for bladder cancer
Faysal A. Yafi et al.
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS (2015)
Stratification based on methylation of TBX2 and TBX3 into three molecular grades predicts progression in patients with pTa-bladder cancer
Willemien Beukers et al.
MODERN PATHOLOGY (2015)
Bladder tumour antigen (BTA stat) test compared to the urine cytology in the diagnosis of bladder cancer: A meta-analysis
Aiye Guo et al.
CUAJ-Canadian Urological Association Journal (2014)
The Economics of Bladder Cancer: Costs and Considerations of Caring for This Disease
Robert S. Svatek et al.
EUROPEAN UROLOGY (2014)
ICUD-EAU International Consultation on Bladder Cancer 2012: Screening, Diagnosis, and Molecular Markers
Ashish M. Kamat et al.
EUROPEAN UROLOGY (2013)
Bladder Cancer Diagnosis and Identification of Clinically Significant Disease by Combined Urinary Detection of Mcm5 and Nuclear Matrix Protein 22
John D. Kelly et al.
PLOS ONE (2012)
Projections of the Cost of Cancer Care in the United States: 2010-2020
Angela B. Mariotto et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2011)
Fibroblast Growth Factor Receptor 3 Mutation Analysis on Voided Urine for Surveillance of Patients with Low-Grade Non-Muscle-Invasive Bladder Cancer
Tahlita C. M. Zuiverloon et al.
CLINICAL CANCER RESEARCH (2010)
Meta-analysis: does lidocaine gel before flexible cystoscopy provide pain relief?
David S. Aaronson et al.
BJU INTERNATIONAL (2009)
Recurrence, Progression, and Follow-Up in Non-Muscle-Invasive Bladder Cancer
Antoine G. van der Heijden et al.
EUROPEAN UROLOGY SUPPLEMENTS (2009)
UroVysion FISH test for detecting urothelial cancers: Meta-analysis of diagnostic accuracy and comparison with urinary cytology testing
Tine Hajdinjak
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS (2008)
Predicting recurrence and progression in individual patients with stage Ta T1 bladder cancer using EORTC risk tables: A combined analysis of 2596 patients from seven EORTC trials
RJ Sylvester et al.
EUROPEAN UROLOGY (2006)
Bladder carcinoma in situ in 2003: State of the art
JA Witjes
EUROPEAN UROLOGY (2004)
Comparison of the ImmunoCyt test and urinary cytology with other urine tests in the detection and surveillance of bladder cancer
MI Toma et al.
WORLD JOURNAL OF UROLOGY (2004)
Sensitivity and specificity of commonly available bladder tumor markers versus cytology: Results of a comprehensive literature review and meta-analyses
Y Lotan et al.
UROLOGY (2003)
Patient opinion of urinary tests versus flexible urethrocystoscopy in follow-up examination for superficial bladder cancer: A utility analysis
JLJ Vriesema et al.
UROLOGY (2000)